Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease

Abstract

BackgroundBackground: Alzheimer’s disease (AD) is the most common form of old age dementia. The formation of amyloid plaques (Aβ), neurofibrillary tangles and loss of basal forebrain cholinergic neurons are the hallmark events in the pathology of AD.Literature ReviewCholinergic system is one of the most important neurotransmitter system involved in learning and memory which preferentially degenerates in the initial stages of AD. Activation of cholinergic receptors (muscarinic and nicotinic) activates multiple pathways which result in post translational modifications (PTMs) in multiple proteins which bring changes in nervous system. Cholinergic receptors-mediated PTMs “in-part” substantially affect the biosynthesis, proteolysis, degradation and expression of many proteins and in particular, amyloid precursor protein (APP). APP is subjected to several PTMs (proteolytic processing, glycosylation, sulfation, and phosphorylation) during its course of processing, resulting in Aβ deposition, leading to AD. Aβ also alters the PTMs of tau which is a microtubule associated protein. Therefore, post-translationally modified tau and Aβ collectively aggravate the neuronal loss that leads to cholinergic hypofunction.ConclusionDespite the accumulating evidences, the interaction between cholinergic neurotransmission and the physiological significance of PTM events remain speculative and still needs further exploration. This review focuses on the role of cholinergic system and discusses the significance of PTMs in pathological progression of AD and highlights some important future directions.

Neuroprotective Effects of Quercetin in Alzheimer’s Disease

“…Choline acetyltransferase activity is greatly reduced in individuals with AD. It has also been shown that acetyl cholinesterase (AChE) accelerates the aggregation of Aβ [108]. The degeneration of serotonergic neurons in the raphe nucleus and noradrenergic neurons in the locus coeruleus mediates on cognitive symptoms associated with AD [109].…”

Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer’s disease

“…It is defined as the primary degenerative process that can damage cholinergic neurons in the brain and results in cognitive impairment. Neurofibrillary alterations and β‐amyloid pathology interact with cholinergic receptors and accelerate the progression of AD . The cholinergic hypothesis has served the basis for the majority of treatment strategies and drug development approaches toward AD till date.…”

Rho‐associated coiled‐coil kinase 1 activation mediates amyloid precursor protein site‐specific Ser655 phosphorylation and triggers amyloid pathology

“…Post‐translational modification of APP has been a focus of research in the field of AD, including examinations of APP glycosylation, ubiquitination, and phosphorylation (Marcelli et al, ). These modifications have been proposed as regulatory mechanisms to affect APP trafficking and cleavage, signal transduction, and axonal outgrowth (Ahmed, Zahid, Mahboob, & Farhat, ; Ando, Iijima, Elliott, Kirino, & Suzuki, ; Schedin‐Weiss, Winblad, & Tjernberg, ). Since APP processing and Aβ production involve intracellular fragment transport and vesicle trafficking, APP processing can be regulated via modulating its phosphorylation.…”